Envestnet Asset Management Inc. grew its stake in Relx NV (NYSE:RENX) by 2,365.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 393,324 shares of the technology company’s stock after purchasing an additional 377,370 shares during the period. Envestnet Asset Management Inc.’s holdings in Relx were worth $8,390,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Natixis Advisors L.P. grew its position in Relx by 0.8% in the 1st quarter. Natixis Advisors L.P. now owns 409,300 shares of the technology company’s stock worth $8,509,000 after purchasing an additional 3,361 shares during the last quarter. Wells Fargo & Company MN grew its position in Relx by 14.0% in the 1st quarter. Wells Fargo & Company MN now owns 298,522 shares of the technology company’s stock worth $6,207,000 after purchasing an additional 36,732 shares during the last quarter. Millennium Management LLC grew its position in Relx by 334.0% in the 1st quarter. Millennium Management LLC now owns 237,863 shares of the technology company’s stock worth $4,945,000 after purchasing an additional 183,051 shares during the last quarter. Aperio Group LLC lifted its holdings in shares of Relx by 42.9% during the 2nd quarter. Aperio Group LLC now owns 227,569 shares of the technology company’s stock worth $4,854,000 after acquiring an additional 68,303 shares during the period. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Relx by 34.7% during the 1st quarter. JPMorgan Chase & Co. now owns 225,773 shares of the technology company’s stock worth $4,694,000 after acquiring an additional 58,214 shares during the period. Institutional investors own 1.40% of the company’s stock.
A number of equities analysts have recently commented on RENX shares. Zacks Investment Research downgraded shares of Relx from a “hold” rating to a “sell” rating in a report on Saturday, May 26th. UBS Group downgraded shares of Relx from a “neutral” rating to a “sell” rating in a report on Thursday, June 14th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $23.00.
NYSE:RENX opened at $21.77 on Friday. The stock has a market cap of $20.87 billion, a PE ratio of 20.93, a price-to-earnings-growth ratio of 3.74 and a beta of 0.65. Relx NV has a 52 week low of $20.06 and a 52 week high of $23.30. The company has a quick ratio of 0.37, a current ratio of 0.41 and a debt-to-equity ratio of 2.39.
The firm also recently disclosed a dividend, which was paid on Wednesday, August 29th. Stockholders of record on Friday, August 3rd were issued a dividend of $0.139 per share. This is an increase from Relx’s previous dividend of $0.14. The ex-dividend date was Thursday, August 2nd. Relx’s dividend payout ratio (DPR) is presently 26.92%.
RELX NV, through its interest in RELX Group plc, provides information and analytics for professional and business customers across industries worldwide. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment offers information and analytics to institutions and professionals.
Featured Article: Earnings Per Share
Want to see what other hedge funds are holding RENX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx NV (NYSE:RENX).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.